维普期刊资源整合服务平台（V6.5）

130篇 您的检索式：作者名="Nankivell"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Diagnosis and prevention of chronic kidney allograft loss显示文摘	Nankivell gJ Kuypers DR	2011	Lancet2011，378，9800：	1
2	Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes fi'om the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial 显示文摘	STARK D NANKIVELL M PUJADE-LAURAINE E et al	2013	Lancet Oncol2013，14，3：	1
3	Evolution and pathophys-iology of renal-transplant glomerulosclerosis显示文摘	Nankivell BJ Borrows RJ Fung CL	2004	Transplantation2004，，78：	1
4	Effect of histological damage on long-term kidney transplant outcome显示文摘	Nankivell BJ Fenton-Lee CA Kuypers DR	2001	Transplantation2001，71，4：	1
5	Rejection of the kidney allograft 显示文摘	Nankivell BJ Alexander SI	2010	N Engl J Med2010，363，15：	1
6	Chronic renal allograft dysfunction显示文摘	Chapman J R O'Connell P J Nankivell B J	2005	J Am Soc Nephrol2005，16，10：	1
7	Iron accumulation in humanchronic renal disease显示文摘	Nankivell BJ Boadle RA Harris CH	1992	Am J Kid Dis1992，20，3：	1
8	Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology显示文摘	Nankivell BJ Borrows RJ Fung CL	2004	Transplantation2004，78，4：	1
9	Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial显示文摘	Dan Stark Matthew Nankivell Eric Pujade-Lauraine Gunnar Kristensen Lorraine Elit Martin Stockler Felix Hilpert Andrés Cervantes Julia Brown Anne Lanceley Galina Velikova Eduardo Sabate Jacobus Pfisterer Mark S Carey Philip Beale Wendi Qian Ann Marie Swart	2013	Lancet Oncology2013，，：	1
10	Standard chemotherapy with or without bevacizumab in advanced ovarian cancer:quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial显示文摘	Stark D Nankivell M Pujade-Lauraine E	2013	Lancet 0ncol2013，14，3：	1
11	The risk and in- terval to malignancy of patients with laryngeal dysplasia, a sys- tematic review of case series and meta-analysis显示文摘	Weller MD Nankivell PC McConkey C	2010	Clin Otolaryn- gol2010，35，5：	1
12	Lysosomal iron accumulation in diabetic nephropathy显示文摘	Nankivell BJ Tay YC Boadle RA	1994	Ren Fail1994，16，3：	1
13	The natural history of chronic allograft nephropathy显示文摘	Nankivell BJ Borrows RJ Fung CL	2003	N Engl J Med2003，349，24：	1
14	The natural history of chronic allograft nephropathy显示文摘	NANKIVELL B J BORROWS RJ FUNG CL	2003	N Engl J Med2003，349，24：	1
15	Standard chemotherapy with or without bevacizumab in advanced ovarian cancer:quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms(ICON7)phase3 randomised trial显示文摘	Stark D Nankivell M Pujade-Lauraine E	2013	Lancet Oncol2013，14，3：	1
16	The natural history of chronic allograft nephropathy显示文摘	NANKIVELL B J BORROWS R J FUNG CL	2003	N Engl J Med2003，349，24：	1
17	ORAL CYCLOSPORINE BUT NOT TACROLIMUS REDUCES RENAL TRANSPLANT BLOOD FLOW显示文摘	Brian J. Nankivell Jeremy R. Chapman George Bonovas Simon M. Gruenewald	2004	Transplantation2004，，9：	1
18	Chronic allograft nephropa- thy 显示文摘	Fletcher JT Nankivell B J Alexander SI	2009	Pediatr Nephtol2009，24，：	1
19	The riskand interval to malignancy of patients with laryngeal dysplasia;asystematic review of case series and meta-analysis显示文摘	WELLER MD NANKIVELL PC MCCONKEY C	2010	Clin Oto-laryngol2010，35，5：	1
20	Mycopheno- late mofetil is associated with altered expression of chronic renal transplant histology显示文摘	Nankivell BJ Wavamunno MD Borrows RJ	2007	Am J Transplant2007，7，2：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示